Quan Jin currently serves as the Associate Director of Capsid Engineering at Roche Innovation Center Philadelphia, having joined the company in 2025. Previously, they led capsid engineering efforts at Spark Therapeutics, Inc. and held various positions at Biogen, including as a Scientist II in the Gene Therapy Accelerator Unit. Quan is a PhD candidate in Pharmaceutical Sciences at UNC Chapel Hill, focusing on AAV vector-mediated gene therapies for Duchenne muscular dystrophy, and also possesses a PharmD from Rutgers University, where they are a registered pharmacist in North Carolina.
This person is not in the org chart
This person is not in any teams
This person is not in any offices